NEUROCRINE BIOSCIENCES INC (NBIX)

Import this data to Google Sheets with:

=jivedata("NBIX","financials")

Full statements spill as a table. For one cell: =jivedata("NBIX","Revenue") or =jivedata("NBIX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

NEUROCRINE BIOSCIENCES INC

NBIX • CIK 0000914475

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Available to Common Stockholders, Basic	$249,700	$341,300	$478,600	$705,500
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	—	—	4,000,000	3,700,000
Weighted Average Number of Shares Outstanding, Basic	97,700,000	100,400,000	99,500,000	101,000,000
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements	3,300,000	3,300,000	3,000,000	3,500,000
Weighted Average Number of Shares Outstanding, Diluted	101,000,000	103,700,000	102,500,000	104,500,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$251,100	$233,000	$713,000	$332,400
Debt Securities, Available-for-sale, Current	$780,500	$843,100	$767,400	$57,400
Deferred Income Tax Assets, Net	$362,600	$485,700	$320,300	$8,900
Accounts Receivable, after Allowance for Credit Loss, Current	—	$479,100	$686,800	$887,000
Debt Securities, Available-for-sale, Noncurrent	$687,500	$739,500	$1,063,000	$91,900
Inventory, Net	$38,300	$57,400	$69,000	$104,200
Operating Lease, Right-of-Use Asset	$276,500	$509,400	$455,400	$448,000
Prepaid Expense, Current	—	—	$170,700	$217,100
EquitySecuritiesFvNiCurrentAndNoncurrent	$161,900	$124,800	$120,800	$147,300
Other Assets, Current	$97,800	$112,100	$115,800	$39,400
Property, Plant and Equipment, Net	$70,800	$82,600	$89,800	$90,500
Assets, Current	$1,607,000	$1,724,700	$2,522,700	$1,637,500
Other Assets, Noncurrent	$49,600	$15,500	$59,500	$59,300
Assets	$3,251,400	$3,718,700	$4,631,500	$5,359,100
Operating Lease, Liability, Noncurrent	$258,300	$455,100	$415,300	$401,800
Other Liabilities, Noncurrent	$106,300	$166,200	$219,700	$297,700
Liabilities	$1,019,400	$1,129,000	$1,378,400	$1,665,500
Accounts Payable and Accrued Liabilities, Current	$448,800	$461,600	$674,300	$808,300
Other Liabilities, Current	$35,900	$46,100	$69,100	$66,200
Liabilities, Current	$654,800	$507,700	$743,400	$874,500
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Issued	$100	$100	$100	$100
Additional Paid in Capital, Common Stock	$2,382,000	$2,554,600	$2,792,200	$2,964,400
Accumulated Other Comprehensive Income (Loss), Net of Tax	$7,000	$5,800	$13,100	$5,100
Retained Earnings (Accumulated Deficit)	$-157,100	$29,200	$447,700	$724,000
Stockholders' Equity Attributable to Parent	$2,232,000	$2,589,700	$3,253,100	$3,693,600
Preferred Stock, Shares Authorized	5,000,000	5,000,000	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	220,000,000	220,000,000	220,000,000	220,000,000
Common Stock, Shares, Issued	98,700,000	99,400,000	100,100,000	101,600,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss) Attributable to Parent	$249,700	$341,300	$478,600	$705,500
Net Cash Provided by (Used in) Operating Activities	$389,900	$595,400	$782,700	$898,100
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$300	$0	$0	$-200
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-11,600	$-18,100	$480,000	$66,900
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$259,100	$241,000	$721,000	$793,400
Share-based Payment Arrangement, Noncash Expense	$194,300	$195,500	$217,900	$234,500
Payments to Acquire Debt Securities, Available-for-sale	$1,379,900	$1,056,100	$1,319,800	$1,588,400
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale	$972,400	$967,500	$1,089,400	$3,020,200
Operating Lease, Impairment Loss	—	—	$700	$700
PaymentsToAcquireEquitySecuritiesFvNi	$31,300	$0	$0	$0
Depreciation	$17,800	$23,500	$26,000	$28,700
Payments to Acquire Property, Plant, and Equipment	$28,300	$38,200	$34,000	$27,700
Accretion (Amortization) of Discounts and Premiums, Investments	$18,300	$26,200	$12,700	$6,300
Net Cash Provided by (Used in) Investing Activities	$-467,100	$-126,800	$-264,400	$-891,200
Amortization of Intangible Assets	$3,500	$3,600	$4,100	$18,600
Equity Securities, FV-NI, Unrealized Gain (Loss)	$28,400	$-37,100	$-4,000	$59,800
Deferred Income Taxes and Tax Credits	$-56,700	$-123,100	$165,400	$130,100
Other Operating Activities, Cash Flow Statement	$-900	$24,500	$700	$200
Proceeds from Issuance of Common Stock	$65,300	$122,100	$129,400	$191,300
Payments for Repurchase of Common Stock	—	$300,000	$167,700	$66,000
Repayments of Convertible Debt	$0	$308,800	$0	$0
Net Cash Provided by (Used in) Financing Activities	$65,300	$-486,700	$-38,300	$60,200
Capital Expenditures Incurred but Not yet Paid	$2,500	$2,200	$2,200	$1,600
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	$200,800	$271,600	$0	$-800
Interest Paid, Excluding Capitalized Interest, Operating Activities	$3,800	$1,600	$0	$2,700
Income Taxes Paid	$51,500	$217,500	$81,400	$97,100
Increase (Decrease) in Accounts Receivable	$89,300	$39,800	$210,500	$259,600
Increase (Decrease) in Inventories	$-5,400	$19,100	$15,300	$17,900
Increase (Decrease) in Accounts Payable and Accrued Liabilities	$64,300	$29,000	$160,200	$109,500
Increase (Decrease) in Income Taxes	—	—	$-18,800	$25,600
Increase (Decrease) in Other Operating Assets and Liabilities, Net	$-47,800	$-10,700	$44,400	$22,500

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("NBIX","financials")

Full statements spill as a table. For one cell: =jivedata("NBIX","Revenue") or =jivedata("NBIX","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.